ABT · 10-Q · 2026Q2 · Full report

Gross Margin Drivers

ABBOTT LABORATORIES · 2026-07-28 · Importance 39 · Surprise 50 · From source text

Abbott’s gross profit margin was 52.5% in the second quarter and first six months of 2026, down from 52.7% in both 2025 periods. The 20-basis-point decline primarily reflected higher intangible amortization expense related to the Exact Sciences acquisition and higher costs. Favorable business mix from adding Exact Sciences, margin-improvement initiatives, and foreign exchange partially offset the margin pressure.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
assetspositiverealized+11.3%Gross amount of amortizable intangible assets at June 30, 2026: $39.8 billion and at December 31, 2025: $27.6 billion; gross amortizable…
operating_incomenegativecommitted-9.3%Abbott’s estimated annual amortization expense for intangible assets: approximately $2.6 billion in 2026, $2.3 billion in 2027, $1.8…
operating_incomenegativecommitted-8.2%Abbott’s estimated annual amortization expense for intangible assets: approximately $2.6 billion in 2026, $2.3 billion in 2027, $1.8…
operating_incomenegativecommitted-6.4%Abbott’s estimated annual amortization expense for intangible assets: approximately $2.6 billion in 2026, $2.3 billion in 2027, $1.8…
operating_incomenegativecommitted-6.1%Abbott’s estimated annual amortization expense for intangible assets: approximately $2.6 billion in 2026, $2.3 billion in 2027, $1.8…
operating_incomenegativecommitted-5.4%Abbott’s estimated annual amortization expense for intangible assets: approximately $2.6 billion in 2026, $2.3 billion in 2027, $1.8…
operating_incomenegativerealized-4.2%Accumulated amortization of intangible assets at June 30, 2026: $24.3 billion and at December 31, 2025: $23.3 billion.
assetsnegativerealized-0.9%Accumulated amortization of intangible assets at June 30, 2026: $24.3 billion and at December 31, 2025: $23.3 billion.